Matches in Nanopublications for { ?s ?p "DDI between Bosentan and Lurasidone - Concomitant therapy with a CYP3A4 substrate and inducer will decrease levels of lurasidone. Coadministration with lurasidone is contraindicated. [drugbank_resource:DB00559_DB08815]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.